Massive dilution from this PIPE will pressure the stock post-announcement. The deep discount, combined with 200% warrant coverage, creates heavy overhang. The registration filing within 15 days accelerates the timeline for resale. Traders should anticipate significant selling pressure once the S-3 becomes effective. The 90-day lock on other equity raises offers temporary protection but does not mitigate the current dilution.
Price Chart
Executive Summary
Bluejay Diagnostics has entered into a securities purchase agreement to raise approximately $8.5 million through a private placement priced at $2.325 per share, coupled with Series G ($2.075 strike, 5-year term) and Series H ($2.075 strike, 2-year term) warrants exercisable for 100% coverage each. The company also issued a placement agent warrant with a $2.9063 strike. Proceeds are earmarked for working capital, and the transaction imposes a 90-day hard lock and a 12-month ban on variable-rate transactions. For a micro-cap with a ~$5M market cap, this is a highly dilutive capital raise that existing shareholders will absorb.
Key Financial Metrics
Key Facts
- Raised ~$8.5M through a PIPE at $2.325/share, a deep discount likely to the prevailing market price for a micro-cap.
- Purchasers received Series G (5-yr, $2.075 strike) and Series H (24-month, $2.075 strike) warrants for 100% of their share/pre-funded warrant allocation each – total potential dilution equals ~3x the base shares issued.
- Placement agent H.C. Wainwright received warrants at $2.9063 strike (5-yr term), adding further overhang.
- Registration rights agreement requires filing an S-3 resale registration within 15 days with a 45-day effectiveness target (75 days on full review), enabling near-term resale of the PIPE shares and warrant shares.
- 90-day lock-up on new equity issuances (except exempt grants) and 12-month ban on variable-rate transactions (equity lines/ATMs), precluding certain near-term capital alternatives.
- Proceeds stated for working capital use, with restrictions on debt repayment (excluding trade payables), stock redemption, litigation settlement, and FCPA/OFAC violations.
- Non-disclosure provisions for material, non-public information are effectively waived for purchasers post-disclosure.
Financial Impact
The offering represents ~170% of the pre-offering market cap. Total potential dilution from shares + all warrants could exceed 600% of pre-offering shares if fully exercised, drastically reducing per-share value for existing holders.
Risk Factors
- Massive dilution: ~3x base shares plus additional placement agent warrants could flood the float.
- Warrant exercise risk: $2.075 strike offers immediate intrinsic value (if current price > strike), incentivizing cashless or cash exercises, further diluting existing holders.
- Resale registration readies the PIPE shares for immediate sale into the market within weeks.
- Micro-cap volatility: a $5M market cap is highly susceptible to order flow from any selling by PIPE investors.
- Nasdaq compliance risk: the company may slip below minimum bid price or market value of listed securities post-dilution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-066364 |
| Document: ea029339001ex10-2.htm | 0001213900-26-066364 |
| Document: ea029339001ex4-4.htm | 0001213900-26-066364 |
| Document: ea029339001ex4-2.htm | 0001213900-26-066364 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 8-K | $0.8323 | awaiting T+20 | — | $0.5600 (−32.72%) |
Oct 6, 2026 20d ago | 8-K | $0.8107 | awaiting T+20 | — | $0.5600 (−30.92%) |
Aug 13, 2026 10w ago | 8-K | $1.06 | awaiting T+20 | — | $0.5600 (−47.17%) |
Aug 13, 2026 10w ago | Press Release | $1.06 | awaiting T+20 | — | $0.5600 (−47.17%) |
Jul 22, 2026 13w ago | 8-K | $1.14 $0.9393 | ▼ −17.61% | ▼ −20.91% | $0.5600 (−50.88%) |
Jul 13, 2026 15w ago | 3 | $1.22 $0.9872 | ▼ −19.08% | ▼ −22.27% | $0.5600 (−54.10%) |
Jul 10, 2026 15w ago | 3 | $1.45 $1.07 | ▼ −26.21% | ▼ −28.63% | $0.5600 (−61.38%) |
Jun 29, 2026 17w ago | EFFECT | $1.44 $1.03 | ▲ +28.47% | ▲ +28.19% | $0.5600 (+61.11%) |
Jun 17, 2026 18w ago | S-3 | $4.46 $1.30 | ▲ +70.85% | ▲ +71.39% | $0.5600 (+87.44%) |
Jun 9, 2026 19w ago | 8-K | $4.49 $1.40 | ▼ −68.82% | ▼ −72.44% | $0.5600 (−87.53%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers